EUVIMEDEUVIMED entdecken
Kohortenstudie

A reappraisal of the epidemiology of Spitz neoplasms in the molecular era: A retrospective cohort study

Michael Hagstrom, Soneet Dhillon, Mónica Fumero-Velázquez, Shantel Olivares, Pedram Gerami

Journal of the American Academy of Dermatology · 2023

DOI: 10.1016/j.jaad.2023.08.005 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of the American Academy of Dermatology, 2023. Verfasst von Michael Hagstrom und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL. Hauptthemen laut MEDLINE: Skin Neoplasms, Nevus, Epithelioid and Spindle Cell, Melanoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: IDP Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Previous studies suggest that Spitz neoplasms occur primarily in younger patients, leading pathologists to shy away from diagnosing a benign Spitz neoplasm in the elderly. With the advent of genomic sequencing, there is a need for reappraisal of the epidemiology of Spitz neoplasms in the modern molecular era. OBJECTIVE: We aim to reassess the epidemiology of Spitz neoplasms incorporating next-generation sequencing. METHODS: We looked at 53,814 non-Spitz neoplasms and 1260 Spitz neoplasms including 286 Spitz neoplasms with next-generation sequencing testing and collected various epidemiologic data. RESULTS: In our general pool of cases, the proportion of Spitz neoplasm cases occurring is relatively the same in each of the first 4 decades of life with a precipitous drop in the fifth decade. In assessing a group of genomically verified cases of Spitz neoplasms, the drop was much less significant and up to 20% of all Spitz neoplasm cases occurred in patients over 50 years of age. LIMITATIONS: Limitations included the number of genetically verified Spitz neoplasm cases available and a possible bias as to which cases undergo genomic testing. CONCLUSION: Genomic verification may allow more confident diagnosis of Spitz neoplasms in patients over 50 years of age and avoid melanoma overdiagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsNevus, Epithelioid and Spindle CellMelanomaHumansMiddle AgedAgedRetrospective StudiesDiagnosis, Differential

Stichwörter der Autor:innen

Spitzdermatopathologyepidemiologygenomicsmelanomapigmented lesions

Autor:innen und Institutionen

  • Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
  • Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL. Electronic address: pedram.gerami@nm.org.

Förderung

  • IDP Foundation

Zitieren

APA

Hagstrom, M., Dhillon, S., Fumero-Velázquez, M., Olivares, S., & Gerami, P. (2023). A reappraisal of the epidemiology of Spitz neoplasms in the molecular era: A retrospective cohort study. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2023.08.005

Vancouver

Hagstrom M, Dhillon S, Fumero-Velázquez M, Olivares S, Gerami P. A reappraisal of the epidemiology of Spitz neoplasms in the molecular era: A retrospective cohort study. Journal of the American Academy of Dermatology. 2023. doi:10.1016/j.jaad.2023.08.005

BibTeX
@article{Hagstrom2023,
  author = {Hagstrom, Michael and Dhillon, Soneet and Fumero-Velázquez, Mónica and Olivares, Shantel and Gerami, Pedram},
  title = {A reappraisal of the epidemiology of Spitz neoplasms in the molecular era: A retrospective cohort study},
  journal = {Journal of the American Academy of Dermatology},
  year = {2023},
  doi = {10.1016/j.jaad.2023.08.005}
}
Kostenlos starten →